Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

Nonalcoholic fatty liver disease as a risk factor for Clostridium Difficille-associated diarrhea.

Nseir WB, Hussein SHH, Farah R, Mahamid MN, Khatib HH, Mograbi JM, Peretz A, Amara AE.

QJM. 2019 Nov 5. pii: hcz283. doi: 10.1093/qjmed/hcz283. [Epub ahead of print]

PMID:
31688897
2.

Characterization of the Immune Response during Infection Caused by Clostridioides difficile.

Hamo Z, Azrad M, Nitzan O, Peretz A.

Microorganisms. 2019 Oct 10;7(10). pii: E435. doi: 10.3390/microorganisms7100435.

3.

Characteristics of hospitalised patients with influenza in 2015-2016 in northern Israel: three circulating strains and continued fear of 2009 A/H1N1.

Kalish T, Miron D, Azrad M, Rechnitzer H, Ben-Amram H, Glikman D, Peretz A.

Epidemiol Infect. 2019 Sep 25;147:e278. doi: 10.1017/S0950268819001407.

4.

Maternal and neonatal outcome of asymptomatic bacteriuria at term pregnancy.

Perlitz Y, Saffoury E, Shabso N, Labai A, Namatiyof JF, Nitzan O, Ben-Shlomo I, Azrad M, Ben-Ami M, Peretz A.

Pathog Dis. 2019 Jul 1;77(5). pii: ftz046. doi: 10.1093/femspd/ftz046.

PMID:
31549172
5.

Molecular typing of Cryptosporidium in Israel.

Grossman T, Ken-Dror S, Pavlotzky E, Vainer J, Glazer Y, Sagi O, Peretz A, Agmon V, Marva E, Valinsky L.

PLoS One. 2019 Sep 3;14(9):e0219977. doi: 10.1371/journal.pone.0219977. eCollection 2019.

6.

Molecular Characterization and Moxifloxacin Susceptibility of Clostridium difficile.

Mizrahi S, Hamo Z, Azrad M, Peretz A.

Antibiotics (Basel). 2019 Aug 12;8(3). pii: E118. doi: 10.3390/antibiotics8030118.

7.

The Prevalence of Cryptosporidium among Children Hospitalized because of Gastrointestinal Symptoms and the Efficiency of Diagnostic Methods for Cryptosporidium.

Golan Shaposhnik E, Abozaid S, Grossman T, Marva E, On A, Azrad M, Peretz A.

Am J Trop Med Hyg. 2019 Jul;101(1):160-163. doi: 10.4269/ajtmh.19-0057.

PMID:
31115293
8.

Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy.

Nuriel-Ohayon M, Neuman H, Ziv O, Belogolovski A, Barsheshet Y, Bloch N, Uzan A, Lahav R, Peretz A, Frishman S, Hod M, Hadar E, Louzoun Y, Avni O, Koren O.

Cell Rep. 2019 Apr 16;27(3):730-736.e3. doi: 10.1016/j.celrep.2019.03.075.

9.

Antimicrobial agent susceptibilities of Legionella pneumophila MLVA-8 genotypes.

Sharaby Y, Nitzan O, Brettar I, Höfle MG, Peretz A, Halpern M.

Sci Rep. 2019 Apr 16;9(1):6138. doi: 10.1038/s41598-019-42425-1.

10.

Detection of group a Streptococcus in pharyngitis by two rapid tests: comparison of the BD Veritor™ and the QuikRead go® Strep A.

Azrad M, Danilov E, Goshen S, Nitzan O, Peretz A.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1179-1185. doi: 10.1007/s10096-019-03527-w. Epub 2019 Mar 9.

PMID:
30852698
11.

High Rates of Fosfomycin Resistance in Gram-Negative Urinary Isolates from Israel.

Peretz A, Naamneh B, Tkhawkho L, Nitzan O.

Microb Drug Resist. 2019 Apr;25(3):408-412. doi: 10.1089/mdr.2018.0393. Epub 2019 Feb 6.

PMID:
30724694
12.

Cheap and rapid in-house method for direct identification of positive blood cultures by MALDI-TOF MS technology.

Azrad M, Keness Y, Nitzan O, Pastukh N, Tkhawkho L, Freidus V, Peretz A.

BMC Infect Dis. 2019 Jan 18;19(1):72. doi: 10.1186/s12879-019-3709-9.

13.

Influenza virus and atherosclerosis.

Peretz A, Azrad M, Blum A.

QJM. 2019 Oct 1;112(10):749-755. doi: 10.1093/qjmed/hcy305.

PMID:
30605546
14.

In vitro activity of Tedizolid and Dalbavancin against MRSA strains is dependent on infection source.

Azrad M, Baum M, Rokney A, Levi Y, Peretz A.

Int J Infect Dis. 2019 Jan;78:107-112. doi: 10.1016/j.ijid.2018.11.011. Epub 2018 Nov 20.

15.

Haploseek: a 24-hour all-in-one method for preimplantation genetic diagnosis (PGD) of monogenic disease and aneuploidy.

Backenroth D, Zahdeh F, Kling Y, Peretz A, Rosen T, Kort D, Zeligson S, Dror T, Kirshberg S, Burak E, Segel R, Levy-Lahad E, Zangen D, Altarescu G, Carmi S, Zeevi DA.

Genet Med. 2019 Jun;21(6):1390-1399. doi: 10.1038/s41436-018-0351-7. Epub 2018 Nov 19.

PMID:
30449887
16.

The effect of repeated biopsy on pre-implantation genetic testing for monogenic diseases (PGT-M) treatment outcome.

Priner S, Altarescu G, Schonberger O, Holzer H, Rubinstein E, Dekel N, Peretz A, Eldar-Geva T.

J Assist Reprod Genet. 2019 Jan;36(1):159-164. doi: 10.1007/s10815-018-1359-2. Epub 2018 Nov 6.

PMID:
30402730
17.

Fine and Coarse Particulate Matter Exposures and Associations with Acute Cardiac Events among Participants in a Telemedicine Service: A Case-Crossover Study.

Nirel R, Adar SD, Dayan U, Vakulenko-Lagun B, Golovner M, Levy I, Alon Z, Peretz A.

Environ Health Perspect. 2018 Sep;126(9):97003. doi: 10.1289/EHP2596.

18.

Small RNA sequences derived from pre-microRNAs in the supraspliceosome.

Mahlab-Aviv S, Boulos A, Peretz AR, Eliyahu T, Carmel L, Sperling R, Linial M.

Nucleic Acids Res. 2018 Nov 16;46(20):11014-11029. doi: 10.1093/nar/gky791.

19.

Characteristics of Antibiotic Resistance of Helicobacter pylori Among Adult Arab and Jewish Populations in Northern Israel.

Yeganeh M, Paritsky M, On A, Azrad M, Roshrosh H, Moalem R, Peretz A.

Microb Drug Resist. 2019 Jan/Feb;25(1):103-107. doi: 10.1089/mdr.2018.0148. Epub 2018 Aug 21.

PMID:
30129819
20.

Elevated serum immunoglobulin A levels in patients with Clostridium difficile infection are associated with mortality.

Azrad M, Hamo Z, Tkhawkho L, Peretz A.

Pathog Dis. 2018 Aug 1;76(6). doi: 10.1093/femspd/fty066.

PMID:
30124816
21.

Presence of anaerobic bacteria in the urinary tract of catheterized ICU patients.

Rozenfeld KL, Nitzan O, Peretz A.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2131-2136. doi: 10.1007/s10096-018-3349-9. Epub 2018 Aug 18.

PMID:
30121803
22.

Antimicrobial Susceptibility of Environmental Non-O1/Non-O139 Vibrio cholerae Isolates.

Laviad-Shitrit S, Sharaby Y, Izhaki I, Peretz A, Halpern M.

Front Microbiol. 2018 Aug 2;9:1726. doi: 10.3389/fmicb.2018.01726. eCollection 2018.

23.

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile.

Binyamin D, Nitzan O, Azrad M, Hamo Z, Koren O, Peretz A.

Front Microbiol. 2018 Jun 11;9:1256. doi: 10.3389/fmicb.2018.01256. eCollection 2018.

24.

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009-June 20151.

Regev-Yochay G, Reisenberg K, Katzir M, Wiener-Well Y, Rahav G, Strahilevitz J, Istomin V, Tsyba E, Peretz A, Khakshoor S, Dagan R; Israeli Adult Invasive Pneumococcal Disease Group.

Emerg Infect Dis. 2018 Jul;24(7):1275-1284. doi: 10.3201/eid2407.170721.

25.

Infectious disease burden and antibiotic prescribing in primary care in Israel.

Low M, Almog R, Balicer RD, Liberman N, Raz R, Peretz A, Nitzan O.

Ann Clin Microbiol Antimicrob. 2018 Jun 9;17(1):26. doi: 10.1186/s12941-018-0278-5.

26.

Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli: comparison between Etest and a broth dilution method.

Azrad M, Tkhawkho L, Isakovich N, Nitzan O, Peretz A.

Ann Clin Microbiol Antimicrob. 2018 May 23;17(1):23. doi: 10.1186/s12941-018-0275-8.

27.

In Vitro Antileishmanial Activity of a Black Morel, Morchella importuna (Ascomycetes).

Peretz A, Zabari L, Pastukh N, Avital N, Masaphy S.

Int J Med Mushrooms. 2018;20(1):71-80. doi: 10.1615/IntJMedMushrooms.2018025313.

PMID:
29604914
28.

Virulence Traits of Environmental and Clinical Legionella pneumophila Multilocus Variable-Number Tandem-Repeat Analysis (MLVA) Genotypes.

Sharaby Y, Rodríguez-Martínez S, Pecellin M, Sela R, Peretz A, Höfle MG, Halpern M, Brettar I.

Appl Environ Microbiol. 2018 May 1;84(10). pii: e00429-18. doi: 10.1128/AEM.00429-18. Print 2018 May 15.

29.

Inactivation gating of Kv7.1 channels does not involve concerted cooperative subunit interactions.

Meisel E, Tobelaim W, Dvir M, Haitin Y, Peretz A, Attali B.

Channels (Austin). 2018 Jan 1;12(1):89-99. doi: 10.1080/19336950.2018.1441649.

30.

Introducing the Migraine Action Plan.

Peretz AM, Minen MT, Cowan R, Strauss LD.

Headache. 2018 Feb;58(2):195. doi: 10.1111/head.13256. No abstract available.

PMID:
29411373
31.

Migraine Action Plan (MAP).

Peretz AM, Minen MT, Cowan R, Strauss LD.

Headache. 2018 Feb;58(2):355-356. doi: 10.1111/head.13255. No abstract available.

PMID:
29411363
32.

Topical Paromomycin for treating solitary mucosal leishmaniasis.

Kassem R, Peretz A, Porat Ben Amy D.

Int J Dermatol. 2018 Jun;57(6):721-723. doi: 10.1111/ijd.13930. Epub 2018 Jan 29. No abstract available.

PMID:
29377089
33.

Role of Single Procalcitonin Test on Admission as a Biomarker for Predicting the Severity of Clostridium difficile Infection.

Hamo Z, Azrad M, Nitzan O, Sagie A, Tkhawkho L, Binyamin D, Peretz A.

Front Microbiol. 2017 Dec 19;8:2532. doi: 10.3389/fmicb.2017.02532. eCollection 2017.

34.

Tinea capitis-like infection caused by Rhodotorula mucilaginosa in a shelter for African Refugee Children in Northern Israel.

Peretz A, Nitzan O, Freidus V, Kassem R.

Acta Trop. 2018 Mar;179:44-46. doi: 10.1016/j.actatropica.2017.12.016. Epub 2017 Dec 13.

PMID:
29247617
35.

M-current inhibition rapidly induces a unique CK2-dependent plasticity of the axon initial segment.

Lezmy J, Lipinsky M, Khrapunsky Y, Patrich E, Shalom L, Peretz A, Fleidervish IA, Attali B.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10234-E10243. doi: 10.1073/pnas.1708700114. Epub 2017 Nov 6.

36.

[RESISTANCE OF HELICOBACTER PYLORI TO ANTIBIOTICS IN ISRAEL: PAST VS PRESENT].

Peretz A, Paritsky M, Brodsky D, Pastukh N, On A.

Harefuah. 2017 Oct;156(10):642-644. Review. Hebrew.

PMID:
29072383
37.
38.

[PADEH-PORIYA - A CULTURE OF QUALITY AND EXCELLENCE IN THE GALILEE].

Peretz A, Onn E.

Harefuah. 2017 Oct;156(10):616-618. Hebrew.

PMID:
29072376
39.

GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones.

Pastukh N, Binyamin D, On A, Paritsky M, Peretz A.

Helicobacter. 2017 Dec;22(6). doi: 10.1111/hel.12447. Epub 2017 Oct 23.

PMID:
29058343
40.

Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.

Pastukh N, Peretz A, Brodsky D, Isakovich N, Azrad M, On A.

J Glob Antimicrob Resist. 2018 Mar;12:175-178. doi: 10.1016/j.jgar.2017.10.004. Epub 2017 Oct 13.

PMID:
29033302
41.

Ca2+-Calmodulin and PIP2 interactions at the proximal C-terminus of Kv7 channels.

Tobelaim WS, Dvir M, Lebel G, Cui M, Buki T, Peretz A, Marom M, Haitin Y, Logothetis DE, Hirsch JA, Attali B.

Channels (Austin). 2017 Nov 2;11(6):686-695. doi: 10.1080/19336950.2017.1388478. Epub 2017 Nov 17.

42.

Destruction of Clostridium difficile spores colitis using acidic electrolyzed water.

Tkhawkho L, Jackson K, Nitzan O, Peretz A.

Am J Infect Control. 2017 Sep 1;45(9):1053. doi: 10.1016/j.ajic.2017.06.026. No abstract available.

PMID:
28863807
43.

Antimicrobial susceptibility of Clostridium difficile isolates in Israel.

Tkhawkho L, Nitzan O, Pastukh N, Brodsky D, Jackson K, Peretz A.

J Glob Antimicrob Resist. 2017 Sep;10:161-164. doi: 10.1016/j.jgar.2017.04.005. Epub 2017 Jul 17.

PMID:
28729205
44.

Case Report: Infectious Diseases in Pilgrims Visiting the Holy Land.

Nitzan O, Blum A, Marva E, Katz A, Tzadok BS, Nachum-Biala Y, Baneth G, Peretz A.

Am J Trop Med Hyg. 2017 Aug;97(2):611-614. doi: 10.4269/ajtmh.17-0097. Epub 2017 Jul 19.

45.

A comparison of enriched culture and Xpert polymerase chain reaction assay of Group B streptococcus carrier status at 35-37-week gestation to labor onset: a prospective controlled study.

Perlitz Y, Ben-Ami M, Megory EC, Nitzan O, Bouganim T, Younis JS, Shapso N, Peretz A.

J Matern Fetal Neonatal Med. 2018 Aug;31(16):2170-2174. doi: 10.1080/14767058.2017.1338255. Epub 2017 Aug 6.

PMID:
28583016
46.

Lingua Villosa Nigra.

Kriem S, Peretz A, Blum A.

Isr Med Assoc J. 2017 Feb;19(2):131. No abstract available.

47.

Microbiologic Data in Acute Cholecystitis: Ten Years' Experience from Bile Cultures Obtained during Percutaneous Cholecystostomy.

Nitzan O, Brodsky Y, Edelstein H, Hershko D, Saliba W, Keness Y, Peretz A, Chazan B.

Surg Infect (Larchmt). 2017 Apr;18(3):345-349. doi: 10.1089/sur.2016.232. Epub 2017 Mar 6.

PMID:
28394748
48.

[Rheumatoid arthritis and hand surgery].

Peretz AS, Madsen OR, Brogren E, Dahlin L, Søe NH.

Ugeskr Laeger. 2017 Mar 13;179(11). pii: V09160677. Review. Danish.

PMID:
28330532
49.

SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias.

Haron-Khun S, Weisbrod D, Bueno H, Yadin D, Behar J, Peretz A, Binah O, Hochhauser E, Eldar M, Yaniv Y, Arad M, Attali B.

EMBO Mol Med. 2017 Apr;9(4):415-429. doi: 10.15252/emmm.201606937.

50.

Temperature-Dependent Growth Modeling of Environmental and Clinical Legionella pneumophila Multilocus Variable-Number Tandem-Repeat Analysis (MLVA) Genotypes.

Sharaby Y, Rodríguez-Martínez S, Oks O, Pecellin M, Mizrahi H, Peretz A, Brettar I, Höfle MG, Halpern M.

Appl Environ Microbiol. 2017 Mar 31;83(8). pii: e03295-16. doi: 10.1128/AEM.03295-16. Print 2017 Apr 15.

Supplemental Content

Loading ...
Support Center